VTRS Factor Report

Data as of market close on: 6/21/2024.

Fundamental analysis of VTRS using the major investing factors, including value, quality, momentum, and low volatility.
View User Guide    Video Tutorial

Get A Detailed Fundamental Analysis of VTRS Using 22 Time-Tested Investment Strategies

Start a Free Trial

VIATRIS INC (VTRS) Fundamentals

View Guru Analysis
Latest Close: $10.47 Market Cap ($ mil): $12,466 Sector: Healthcare Industry: Biotechnology & Drugs 52 Week High: $13.62 52 Week Low: $8.74 Relative Strength: 58 Twelve Minus One Return: 8.3% Standard Deviation: 32.8% Insider Ownership: 0.37%
PE Ratio: N/A Price/Sales: 0.8 Price/Book: 0.6 Price/Cash Flow: 4.7 EV/EBITDA: 7.01 Dividend Yield: 4.58% Shareholder Yield: -18.92% Piotroski F Score: 7 Mohanram G Score: 5 Institutional Ownership: 83.52%
Return on Equity: -0.3% Return on Assets: -0.1% Return on Tangible Capital: 13.8% Return on Invested Capital: -2.6% WACC: 1.5% Debt/Equity: 0.90 LT EPS Growth: -3.3% LT Sales Growth: 7.5% Beta: 0.94 Profit Margin: -0.36%
Viatris Inc. is a global healthcare company. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment reflects its operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America, and the Middle East, as well as the Company's ARV franchise. The Company's portfolio comprises approved molecules across a range of key therapeutic areas, including globally recognized iconic and key brands and generics, including complex products. The Company operates approximately 30 manufacturing sites worldwide that produce oral solid doses, injectables and complex dosage forms.

Factor Profile

VTRS's exposure to the major factors (100 is highest).

Comparable Stocks

Stocks with the closest factor profiles to VTRS.

(click ticker to access stock report and name to view guru analysis)

Ticker Ticker
ERIC LUV
XRAY SATS
KNX HPE
Performance Disclaimer: Returns presented on Validea.com are model returns and do not represent actual trading. As a result, they do not incorporate any commissions or other trading costs or fees. Model portfolios with inception dates on or after 12/30/2005 include a combination of back tested and live model returns. The back-tested performance results shown are hypothetical and are not the result of real-time management of actual accounts. The back-testing of performance differs from actual account performance because the investment strategy may be adjusted at any time, for any reason and can continue to be changed until desired or better performance results are achieved. Back-tested returns are presented to provide general information regarding how the underlying strategy behind the portfolio performed in our historical testing. A back-tested strategy has the benefit of hindsight and the results do not reflect the impact that material economic or market factors may have had on advisor's decision-making if actual client assets were being managed using this approach. The model portfolios offered on Validea are concentrated and as a result they will exhibit high levels of volatility and their performance can be substantially impacted by the performance of individual positions.

Optimal portfolios presented on Validea.com represent the rebalancing period that has led to the best historical performance for each of our equity models. Each optimal portfolio was determined after the fact with performance information that was not available at portfolio inception. As a result, an investor could not have invested in the optimal portfolio since its inception. Optimal portfolios are presented to allow investors to quickly determine the portfolio size and rebalancing period that has performed best for each of our models in our historical testing.

Both the model portfolio and benchmark returns presented for all equity portfolios on Validea.com are not inclusive of dividends. Returns for our ETF portfolios and trend following system, and the benchmarks they are compared to, are inclusive of dividends. The S&P 500 is presented as a benchmark because it is the most widely followed benchmark of the overall US market and is most often used by investors for return comparison purposes. As with any investment strategy, there is potential for profit as well as the possibility of loss and investors may incur a loss despite a past history of gains. Past performance does not guarantee future results. Results will vary with economic and market conditions.

Validea.com is a research provider that is owned and operated by The Reese Group, LLC. Validea.com offers model portfolios, screening and stock analysis that is not customized to any individual. No information on Validea.com should be construed as investment advice. Validea Capital Management is a separate investment advisory firm registered with the state of Connecticut. Validea Capital offers investment management services directly to clients and is a separate entity from The Reese Group, LLC. The Reese Group and Validea Capital are affiliated entities and share partial common ownership.